⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1161835 | 1.00 | — | — | |
| SCHEMBL13039799 | 1.00 | — | — | |
| SCHEMBL11597748 | 0.81 | AKT1 (0.50) | — | |
| SCHEMBL41825 | 0.79 | — | — | |
| SCHEMBL41826 | 0.79 | — | — | |
| SCHEMBL18131527 | 0.79 | — | — | |
| SCHEMBL22660275 | 0.79 | — | — | |
| SCHEMBL15750770 | 0.79 | — | — | |
| SCHEMBL25276069 | 0.77 | ALDH1A1 (0.42) | — | |
| SCHEMBL2835611 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4685907-A1 | ELECTROLYTE, SECONDARY BATTERY AND ELECTRICAL APPARATUS | Contemporary Amperex Technology Co., Limited (CN) | 2026-01-28 | — | — | EP | disclosed |
| US-20250385311-A1 | ELECTROLYTIC SOLUTION, SECONDARY BATTERY AND ELECTRIC DEVICE | CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) | 2025-12-18 | — | — | US | disclosed |
| WO-2025065868-A1 | ELECTROLYTE, SECONDARY BATTERY AND ELECTRICAL APPARATUS | 宁德时代新能源科技股份有限公司 | 2025-04-03 | — | — | WO | disclosed |
| CN-119725719-A | Electrolyte, secondary battery and electricity utilization device | 宁德时代新能源科技股份有限公司 | 2025-03-28 | — | — | CN | disclosed |
| US-20230293532-A1 | USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK) | PHARMACYCLICS LLC (US) | 2023-09-21 | — | — | US | disclosed |
| US-20230293532-A1 | USE OF INHIBITORS OF BRUTONS TYROSINE KINASE (BTK) | PHARMACYCLICS LLC (US) | 2023-09-21 | — | — | US | disclosed |
| US-20170362246-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | PHARMACYCLICS LLC | 2017-12-21 | — | — | US | disclosed |
| US-9844552-B2 | Methods of treating fibrosis | PHARMACYCLICS LLC (US) | 2017-12-19 | — | — | US | disclosed |
| US-20170354655-A1 | TLR INHIBITOR AND BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS | PHARMACYCLICS LLC | 2017-12-14 | — | — | US | disclosed |
| US-9801883-B2 | Use of inhibitors of bruton's tyrosine kinase (Btk) | PHARMACYCLICS LLC (US) | 2017-10-31 | — | — | US | disclosed |
| US-20100004270-A1 | INHIBITORS OF BRUTON'S TYROSINE KINASE | PHARMACYCLICS, INC. (US) | 2010-01-07 | — | — | US | disclosed |
| US-7514444-B2 | Inhibitors of bruton's tyrosine kinase | PHARMACYCLICS, INC. (US) | 2009-04-07 | — | — | US | disclosed |
| WO-2008121742-A2 | INHIBITORS OF BRUTON'S TYROSINE KINASE | PHARMACYCLICS, INC. (US) | 2008-10-09 | — | — | WO | disclosed |
| US-20080139582-A1 | 4-Amino-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives; can be covalently bonded to Bruton's tyrosine kinase; autoimmune diseases, lymphoma, leukemia; antiproliferative, anticarcinogenic and antiinflammatory agents | PHARMACYCLICS, INC. (US) | 2008-06-12 | — | — | US | disclosed |
| US-20080108636-A1 | compounds that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors of Btk. Methods for the preparation of the compounds are disclosed. Also disclosed are pharmaceutical compositions that include the compounds. Methods of using the Btk inhibitors are told | PHARMACYCLICS, INC. (US) | 2008-05-08 | — | — | US | disclosed |
| US-5004568-A | Reacting With Carbon Monoxide Using A Group 8 Noble Metal Halide Catalyst And A Group 1B Metal Halide | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1991-04-02 | — | — | US | disclosed |
| US-4767574-A | CATALYTIC WITH GROUP 8 NOBLE METAL HALIDE AND HALIDE COMPOUND | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1988-08-30 | — | — | US | disclosed |
| US-4675435-A | CARBONYLATION OF ACYCLIC ALLYLIC ETHER | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1987-06-23 | — | — | US | disclosed |
| EP-0217407-A2 | Carbonylation of allylic ethers to esters | QUANTUM CHEMICAL CORPORATION (a Virginia corp.) (US) | 1987-04-08 | — | — | EP | disclosed |
| US-4622416-A | GROUP 8 HALIDE CATALYSTS | NATIONAL DISTILLERS AND CHEMICAL CORPORATION (US) | 1986-11-11 | — | — | US | disclosed |